The linkage between IL‐6 rs1800797 variant and breast cancer susceptibility in Bangladeshi women: A case‐control study
Open Access
- 6 February 2024
- journal article
- research article
- Published by Wiley in Health Science Reports
- Vol. 7 (2)
Abstract
Background and Aims: Breast cancer is one of the deadliest diseases affecting women in Bangladesh, and its prevalence is increasing year by year. Although several IL‐6 single nucleotide polymorphisms have been implicated in BC susceptibility and prognosis in various studies, no research has been done to investigate the relationship between breast cancer and IL‐6 in Bangladeshi women. This investigation aimed to explore the linkage between the rs1800797 variant of IL‐6 and the susceptibility to breast carcinoma among women in Bangladesh. Methods: The IL‐6 rs1800797 variant was genotyped in 218 subjects (110 cases and 108 controls) using the tetra‐primer ARMS‐PCR method. The statistical analysis was applied utilizing the SPSS software version 24.0. UALCAN database was used for IL‐6 mRNA analysis, and genotype‐based gene expression was retrieved from GTEx Portal. Results: This study found a significant link between IL‐6 rs1800797 variants and increased chance of breast cancer across different genetic inheritance models, including additive model 1 (AG vs. GG: OR = 2.16, p = 0.035); dominant model (AG + AA vs. GG: OR = 2.26, p < 0.05); overdominant model (AG vs. GG + AA: OR = 2.08, p < 0.05); and allelic model (A vs. G: OR = 2.15, p < 0.05). However, an insignificant association of breast cancer was found in both additive model 2 (AA vs. GG: OR = 2.91, p > 0.05) and the recessive model (AA vs. GG + AG: OR = 2.52, p > 0.05). Under the analysis of the probability of false positive reports, no significant values were found in different models when the OR was 1.5, and the prior probability was 0.25. Conclusions: A significant relationship was found between the IL‐6 rs1800797 genetic variant and the risk of breast cancer. However, the findings of the study should be further investigated with a larger sample size to validate the correlation.Keywords
This publication has 24 references indexed in Scilit:
- Genetic polymorphisms of IL-6 promoter in cancer susceptibility and prognosis: a meta-analysisOncotarget, 2018
- Single nucleotide polymorphisms and cancer susceptibilityOncotarget, 2017
- Interleukin (IL-6) ImmunotherapyCold Spring Harbor Perspectives in Biology, 2017
- Gene–environment interaction and risk of breast cancerBritish Journal of Cancer, 2016
- Association of Estrogen Receptor Alpha and Interleukin 6 Polymorphisms with Lymphovascular Invasion, Extranodal Extension, and Lower Disease-Free Survival in Thai Breast Cancer Patients.2016
- IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohortBMC Cancer, 2014
- IL-6 in Inflammation, Immunity, and DiseaseCold Spring Harbor Perspectives in Biology, 2014
- Chronic Inflammation and Cytokines in the Tumor MicroenvironmentJournal of Immunology Research, 2014
- Lung cancer risk in relation to nicotinic acetylcholine receptor, CYP2A6 and CYP1A1 genotypes in the Bangladeshi populationClinica Chimica Acta, 2013
- Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology StudiesJNCI: Journal of the National Cancer Institute, 2004